v3.26.1
Condensed Consolidated Interim Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2026
Mar. 31, 2026
CURRENT ASSETS    
Cash $ 466,503 $ 149,789
Accounts receivable, net 2,397,736 2,932,899
Inventory [Note 3] 1,425,002 1,341,295
Deposits and other receivables 1,306,801 1,432,501
Total current assets 5,596,042 5,856,484
Deposits and other receivables 112,322 109,297
Long-term accounts receivable 93,077 130,847
Property and equipment [Note 12] 2,157 3,646
Operating right of use assets [Note 10] 219,912 346,214
TOTAL ASSETS 6,023,510 6,446,488
CURRENT LIABILITIES    
Accounts payable and accrued liabilities [Note 4] 9,301,716 8,970,870
Convertible promissory notes and short term loans [Note 5] 10,971,841 11,114,209
Term loan, current [Note 6] 14,834,983 14,680,914
Derivative liabilities [Note 8] 450,328 445,893
Advance from customers 1,531,530 1,531,530
Operating lease obligations, current [Note 10] 252,172 397,830
Total current liabilities 37,342,570 37,141,246
Federally guaranteed loans [Note 7] 870,800 870,800
Derivative liabilities [Note 8] 1,502,524 1,396,908
TOTAL LIABILITIES 39,715,894 39,408,954
Mezzanine Equity    
Series B Convertible Redeemable preferred stock, $0.001 and $0.001 par value, 600 and 600 shares authorized as of June 30, 2026 and March 31, 2026, respectively, 335 and 335 shares issued and outstanding as of June 30, 2026 and March 31, 2026, respectively [Note 9] 1,714,476 1,714,476
STOCKHOLDERS’ (DEFICIENCY)    
Common stock, $0.001 and $0.001 par value, 125,000,000 and 125,000,000 shares authorized as at June 30, 2026 and March 31, 2026, respectively. Issued and outstanding common shares: 20,074,675 and 28,597,315 as at June 30, 2026 and March 31, 2026, respectively, and exchangeable shares of 160,672 and 160,672 outstanding as at June 30, 2026 and March 31, 2026, respectively [Note 9] 20,237 28,759
Shares to be issued 581,599 and 1,005,815 shares of common stock as at June 30, 2026 and March 31, 2026, respectively [Note 9] 279,428 284,668
Additional paid-in-capital 105,542,543 107,621,813
Accumulated other comprehensive loss (41,518) (41,940)
Accumulated deficit (143,640,553) (142,570,243)
Total stockholders’ (deficiency) (35,406,860) (34,676,942)
TOTAL LIABILITIES, MEZZANINE AND STOCKHOLDERS’ DEFICIENCY 6,023,510 6,446,488
Preferred Stocks [Member]    
STOCKHOLDERS’ (DEFICIENCY)    
Preferred Stock, value 1 1
Series A Preferred Stock [Member]    
STOCKHOLDERS’ (DEFICIENCY)    
Preferred Stock, value
Series C Preferred Stock [Member]    
STOCKHOLDERS’ (DEFICIENCY)    
Preferred Stock, value $ 2,433,002